Monotherapy with tadalafil or tamsulosin for moderate-to-severe lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): Results from an international, double-blind, placebo-controlled trial

被引：0
|
作者：
Oelke, M. [1 ]
Giuliano, F. [2 ]
Mirone, V [3 ]
Xu, L. [4 ]
Cox, D. [4 ]
Viktrup, L. [4 ]
机构：
[1] Hannover Med Sch, Dept Urol, Hannover, NH, Germany
[2] Versailles St Quentin Univ, R Poincare Hosp, Dept Neurourol Androl, Garches, France
[3] Univ Naples Federico 2, Dept Obstetr Gynaecol Sci & Reprod Med, Naples, Italy
[4] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2012年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E641 / U375
页数：2
相关论文
共 50 条
  • [31] SATISFACTION WITH TADALAFIL OR TAMSULOSIN ONCE DAILY FOR THE TREATMENT OF LUTS/BPH: TREATMENT SATISFACTION SCALE QUESTIONNAIRE RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Oelke, Matthias
    Giuliano, Francois
    Baygani, Simin
    Cox, David
    Sontag, Angelina
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 : 175 - 176
  • [32] Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study
    Zhang, Weiyu
    Zhang, Xiaopeng
    Li, Haibin
    Wu, Feng
    Wang, Huanrui
    Zhao, Meishan
    Hu, Hao
    Xu, Kexin
    BMJ OPEN, 2019, 9 (06):
  • [33] The efficacy and safety of tadalafil administered once a day for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH)
    Roehrborn, CG
    McVary, KT
    Kaminetsky, JC
    Auerbach, SM
    Wachs, B
    Young, JM
    Esler, A
    Sides, GD
    Denes, BS
    JOURNAL OF UROLOGY, 2006, 175 (04): : 527 - 527
  • [34] The efficacy and safety of tadalafil administered once a day for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH)
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 196 - 196
  • [35] Longitudinal association between the dynamic nature of depression with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
    Xie, Zonglan
    Liu, Xuebin
    Hu, Zhigang
    Dong, Chuanjiang
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [36] Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-blind, Multicenter, Placebo-controlled Trial
    Pinggera, Germar-Michael
    Frauscher, Ferdinand
    Paduch, Darius A.
    Bolyakov, Alex
    Efros, Mitchell
    Kaminetsky, Jed
    Da Pozzo, Luigi
    Esler, Anne
    Cox, David
    UROLOGY, 2014, 84 (02) : 412 - 419
  • [37] BOTULINUM TOXIN TYPE A IN THE MANAGEMENT OF LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC HYPERPLASIA: PRELIMINARY RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY
    Sacco, E.
    Totaro, A.
    Vittori, M.
    Tienforti, D.
    Pinto, F.
    D'Addessi, A.
    Racioppi, M.
    Gulino, G.
    Volpe, A.
    Bassi, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 151 - 151
  • [38] Sexual Function in Men with Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia: Results of a 6-Month, Randomized, Double-Blind, Placebo-Controlled Study of Tadalafil Coadministered with Finasteride
    Glina, Sidney
    Roehrborn, Claus G.
    Esen, Adil
    Plekhanov, Alexey
    Sorsaburu, Sebastian
    Henneges, Carsten
    Buettner, Hartwig
    Viktrup, Lars
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 (01): : 129 - 138
  • [39] Tamsulosin oral controlled absorption system (OCAS) in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH):: Efficacy and tolerability in a placebo and active comparator controlled phase 3a study
    Chapple, CR
    Al-Shukri, SH
    Gattegno, B
    Holmes, S
    Martínez-Sagarra, JM
    Scarpa, RM
    Trip, OBV
    Vik, V
    van der Putten-Slob, I
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (02) : 33 - 44
  • [40] EFFICACY AND SAFETY OF TADALAFIL 5 MG ONCE DAILY IN ASIAN MALES WITH LOWER URINARY TRACT SYMPTOMS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH-LUTS): INTEGRATED ANALYSIS FROM 3 ASIAN DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL STUDIES
    Takeda, M.
    Murakami, M.
    Morisaki, Y.
    Viktrup, L.
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (06) : 967 - 969
12345